This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources Sept. 14, 2010
ASCLS eNewsBytes
Sept. 14, 2010
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

Clinical pathology laboratories need to prepare the next generation of lab managers
Dark Daily    Share   Share on FacebookTwitterShare on LinkedinE-mail article
Predictions are that clinical laboratories and pathology groups across the nation will face a growing and serious shortage of skilled managers during the next 24 months. There are two primary reasons why this acute shortage of capable lab managers is soon to develop. First, the oldest baby boomers turn 65 in January and the long - awaited wave of retirements will begin. This means the most experienced staff members in the medical laboratory - managers at the bench level, the section, and the department-will vacate those positions of responsibility. More

Frog skin may provide antimicrobial peptides effective against multidrug-resistant infections
Science Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
P. aeruginosa is an opportunistic pathogen that causes some of the most prevalent life-threatening infections such as eye and ear infections, burn wound infections and lung infections in cystic fibrosis patients. Strains of the bacterium resistant to almost all antibiotics have already emerged causing researchers to seek new drug therapies. More

Insulin may protect patients from fatal bacterial infections
SiFy News    Share    Share on FacebookTwitterShare on LinkedinE-mail
A new study has revealed that treating patients with insulin may reduce their chances of succumbing to an infection. University at Buffalo endocrinologists showed that insulin lowered the amount of inflammation and oxidative stress in study participants who had been injected with a common bacteria, or endotoxin. The bacteria cause hemorrhage, necrosis of the kidneys and shock, especially in immune-compromised patients. More

Function found for protein that causes Alzheimer's disease
Daily News & Analysis    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have found a function for the amyloid precursor protein that yields the prime ingredient in amyloid plaques, which lead to Alzheimer's disease. It turns out that APP is an iron oxidase whose job it is to convert iron from an unsafe form to a safe one for transport or storage. When APP fails to function properly, as it does in Alzheimer's disease, iron levels inside neurons mount to toxic levels. More

Researchers study virus' link to chronic fatigue syndrome
Web MD    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An international group of scientists met this week at the National Institutes of Health to discuss a retrovirus that has been linked to chronic fatigue syndrome and prostate cancer. XMRV (xenotropic murine leukemia virus-related virus) was first identified in humans in 2006. "We are at the very earliest stages" of understanding XMRV, said Cleveland Clinic urologist Eric Klein, MD, part of the team that discovered the virus in men with prostate cancer. More

Bio-Rad's MRSASelect™ - Results on Your Time

Chromogenic Medium for Screening MRSA
With high sensitivity and specificity, this test can identify MRSA carriers in just 18–28 hours. The test procedure is simple, and results are easy to read and interpret. 

Ruling puts research at risk
Houston Chronicle    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The recent ruling banning federal funding for research involving human embryonic stem cells not only threatens work that seeks to alleviate the suffering from major killers, such as Parkinson's, heart disease, stroke and cancer, it could place Texas institutions at an extra disadvantage because there are no state or private foundations established to fund such work. More

Mayo Clinic turning viruses into cancer killers
WCCO-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
At Mayo Clinic Labs in Rochester, Minn., a team of researchers, working in collaboration with the University of Minnesota, has made amazing progress turning various viruses into cancer killers. Mayo's Director of Molecular Medicine, Oncologist Eva Galanis, M.D., points to the proof captured in highly magnified photographs. "These are different cultures of brain tumor cells," said Galanis. The tumor cells fused together and died when invaded with a genetically engineered cousin of the measles virus. More
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!


Jonathan Berger, Director of Advertising Sales

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor

Recent Issues

  • Sep. 7, 2010
  • Aug. 31, 2010
  • Aug. 24, 2010
  • Dedicated - Helmer August 2010
  • Aug. 17, 2010
  •  RSS Feed
    Most popular articles